Sa1244 An Innovative Ex-Vivo Porcine Upper GI Model for Per Oral Endoscopic Tumor Resection (Poet)

2016 ◽  
Vol 83 (5) ◽  
pp. AB270-AB271
Author(s):  
Baldwin P. Yeung ◽  
Philip W. Chiu ◽  
Anthony Y. Teoh ◽  
Linfu Zheng ◽  
Shannon M. Chan ◽  
...  
2020 ◽  
Vol 32 (3) ◽  
pp. 328-336 ◽  
Author(s):  
Manabu Onimaru ◽  
Haruhiro Inoue ◽  
Robert Bechara ◽  
Mayo Tanabe ◽  
Mary Raina Angeli Abad ◽  
...  

2018 ◽  
Vol 87 (6) ◽  
pp. AB257
Author(s):  
Mayo Tanabe ◽  
Shin Kono ◽  
Masaki Ominami ◽  
Masayuki Nishimoto ◽  
Yohei Nishikawa ◽  
...  

2017 ◽  
Vol 85 (5) ◽  
pp. AB499
Author(s):  
Masaki Ominami ◽  
Kazuya Sumi ◽  
Tetsuya Tatsuta ◽  
Yuichiro Ikebuchi ◽  
Haruo Ikeda ◽  
...  

2020 ◽  
Vol 04 (03) ◽  
pp. 273-281
Author(s):  
Masato Fujiki ◽  
Amit Nair ◽  
Giuseppe D'amico ◽  
Mohammed Osman

AbstractVisceral transplantation has been utilized as the most radical surgical treatment for neoplasms not amenable to conventional resection. The main indications for this procedure include mesenteric desmoid tumors threatening the root of mesentery and metastatic neuroendocrine neoplasms. Published case-series of visceral transplantation for such indications are reviewed in this article. Patients with desmoid tumors associated with familial adenomatous polyposis are transplanted with intestinal or multivisceral allografts. With surgical modification of technique, the native spleen is preserved while duodenopancreatic complex is removed to obviate the risk of malignant transformation of duodenal polyposis after transplantation. Preservation of spleen decreased incidence of post-transplant lymphoproliferative disorder, conferring therapeutic advantage. Patient survival is comparable to that of other indications, and desmoid tumor recurrence has been observed in the recipient tissue but not in the donor allograft. For visceral transplantation of metastatic neuroendocrine neoplasms, the majority of these patients have diffuse liver involvement, thus requiring full multivisceral transplantation. Post-transplant patient survival is acceptable with limited data available on recurrence. Autotransplantation following ex vivo tumor resection using visceral allografts has been also performed in a limited, select cohort of patients with various pathologies. Adenocarcinomas are associated with a prohibitive recurrence rate following the procedure, and its use for this indication is therefore not recommended. A national database of visceral transplantation undertaken for neoplastic disease should be developed to better understand predictors of outcomes and to help produce and standardize selection criteria.


Plasma ◽  
2018 ◽  
Vol 1 (1) ◽  
pp. 189-200 ◽  
Author(s):  
Lawan Ly ◽  
Sterlyn Jones ◽  
Alexey Shashurin ◽  
Taisen Zhuang ◽  
Warren Rowe ◽  
...  

The use of plasma energy has expanded in surgery and medicine. Tumor resection in surgery and endoscopy has incorporated the use of a plasma scalpel or catheter for over four decades. A new plasma energy has expanded the tools in surgery: Cold Atmospheric Plasma (CAP). A cold plasma generator and handpiece are required to deliver the CAP energy. The authors evaluated a new Cold Plasma Jet System. The Cold Plasma Jet System consists of a USMI Cold Plasma Conversion Unit, Canady Helios Cold Plasma® Scalpel, and the Canady Plasma® Scalpel in Hybrid and Argon Plasma Coagulation (APC) modes. This plasma surgical system is designed to remove the target tumor with minimal blood loss and subsequently spray the local area with cold plasma. In this study, various operational parameters of the Canady Plasma® Scalpels were tested on ex vivo normal porcine liver tissue. These conditions included various gas flow rates (1.0, 3.0, 5.0 L/min), powers (20, 40, 60 P), and treatment durations (30, 60, 90, 120 s) with argon and helium gases. Plasma length, tissue temperature changes, and depth and eschar injury magnitude measurements resulting from treatment were taken into consideration in the comparison of the scalpels. The authors report that a new cold plasma jet technology does not produce any thermal damage to normal tissue.


2016 ◽  
Vol 48 ◽  
pp. e119
Author(s):  
G.E. Tontini ◽  
H. Neumann ◽  
L. Carmignani ◽  
B. Bruni ◽  
P. Soriani ◽  
...  

2006 ◽  
Vol 132 (3) ◽  
pp. 687-688 ◽  
Author(s):  
H. Jeanmart ◽  
P. Lecompte ◽  
F. Casselman ◽  
J. Coddens ◽  
G. Van Vaerenberg ◽  
...  

2012 ◽  
Vol 187 (4S) ◽  
Author(s):  
Christopher Filson ◽  
Jeffrey Montgomery ◽  
Stephen Dailey ◽  
Heather Crossley ◽  
Paul Al-Attar ◽  
...  

2021 ◽  
Vol 10 (2) ◽  
pp. 06-09
Author(s):  
Danilo Coco ◽  
Silvana Leanza

1. Purpose: The treatment of hepatic neoplasms has undergone, in recent years, various evolution of the surgical technique and extension to the indication for resection. Many patients with liver tumors cannot benefit from resection due to the difficulty of the anatomical site of the lesion.Of these patients, only some can benefit from ex vivo hepatic resection, which consists of a complete hepatectomy, bench tumor resection and self-transplant. 2. Materials and methods: We have retrospectively evaluated PUBMED databases. Studies was evaluated from 2010 to 2020.Only very few studies analyzed “Ex situ liver resection”, “Extracorporeal liver resection”, “Liver auto-transplantation”. Conclusion: Ex vivo liver resection and autotransplantation is fesible in very few patients with unresectable hepatic tumor fit for surgery. R0 resection accounts about 60%-90% but outcomes are less satisfactory due to high complications rate of about 25% and low survival in 3 years.


Sign in / Sign up

Export Citation Format

Share Document